Insulin degludec
Insulin analogues have revolutionized the treatment of diabetes mellitus, and the advent of newer insulin analogues have provided better glycemic control with lesser incidence of hypoglycemia. Insulin degludec is a second-generation, ultra-long-acting acylated basal insulin analogue that possesses a...
Main Authors: | Vishakha V Jain, Omprakash Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Journal of Mahatma Gandhi Institute of Medical Sciences |
Subjects: | |
Online Access: | http://www.jmgims.co.in/article.asp?issn=0971-9903;year=2013;volume=18;issue=2;spage=103;epage=108;aulast=Jain |
Similar Items
-
Degludec insulin: A novel basal insulin
by: Sanjay Kalra, et al.
Published: (2011-01-01) -
Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement
by: Sanjay Kalra, et al.
Published: (2016-01-01) -
Insulin degludec and insulin degludec/insulin aspart in Ramadan: A single center experience
by: Sanjay Kalra
Published: (2016-01-01) -
Modern basal insulins: an ongoing story or the start of a new era?
by: Ivan Ivanovich Dedov
Published: (2015-11-01) -
Insulin degludec is a new ultra-long-acting insulin analogue
by: Ivan Ivanovich Dedov, et al.
Published: (2014-06-01)